第 1/1 張圖片
Lipid A in Cancer Therapy by Jean-Francois Jeannin (English) Hardcover Book
狀況：
運費：
所在地：Fairfield, Ohio, 美國
送達日期：
估計於 5月31日, 五至 6月11日, 二之間送達 運送地點 43230
退貨：
保障：
請參閱物品說明或聯絡賣家以取得詳細資料。閱覽全部詳情查看保障詳情
（不符合「eBay 買家保障方案」資格）
安心購物
物品細節
- 物品狀況
- 全新: 全新，未閱讀過和使用過的書籍，狀況完好，不存在缺頁或內頁受損。 查看所有物品狀況定義會在新視窗或分頁中開啟
- ISBN-13
- 9781441916020
- Book Title
- Lipid A in Cancer Therapy
- ISBN
- 9781441916020
- Series
- Advances in Experimental Medicine and Biology Ser.
- Publication Year
- 2009
- Type
- Textbook
- Format
- Hardcover
- Language
- English
- Publication Name
- Lipid a in Cancer Therapy
- Item Length
- 9.3in
- Publisher
- Springer New York
- Item Width
- 6.1in
- Item Weight
- 12.7 Oz
- Number of Pages
- 152 Pages
關於產品
Product Information
Cancer remains a major challenge for modern society. Not only does cancer rank among the first three causes of mortality in most population groups but also the therapeutic options available for most tumor types are limited. The existing ones have limited efficacy, lack specificity and their administration carry major side effects. Hence the urgent need for novel cancer therapies. One of the most promising avenues in research is the use of specific immunotherapy. The notion that the immune system may have important anti-tumor effects has been around for more than a century now. Every major progress in microbiology and immunology has been immediately followed by attempts to apply the new knowledge to the treatment of cancer. Progress has reached a point where it is well established that most cancer patients mount specific T cell responses against their tumors. The molecular identity of the antigens recognized by anti-tumor T cells has been elucidated and several hundreds of tumor-derived antigenic peptides have been discovered. Upon recognition of such peptides presented by self MHC molecules, both CD8 and CD4 T cells are activated, expand to high numbers and differentiate into effective anti-tumor agents. CD8 T cells directly destroy tumor cells and can cause even large tumors to completely regress in experimental mouse models. These observations have spurred intense research activity aimed at designing and testing cancer vaccines. Over 100 years ago Coley successfully used intratumoral injection of killed bacteria to treat sarcomas. The important anti-tumor effects observed in a fraction of these patients fueled major research efforts. These led to major discoveries in the 80s and the 90s. It turns out that bacterial lipopolysaccharides stimulate the production of massive amounts of a cytokine still known today as tumor necrosis factor (TNF-a). They do so by engagement of a rather complex set of interactions culminating in the ligation of a Toll-like receptor, TLR -4. Ensuing signaling through this receptor initiates potent innate immune responses. Unfortunately the clinical use of both TNF-a and LPS can not be generalized due to their very narrow therapeutic margin. Importantly, synthetic Lipid A analogs have been identified that retain useful bioactivity and yet possess only mild toxicity. The relatively large body of information accumulated thus far on the molecular and cellular interactions set in motion by administration of LPS as well as by the synthetic lipid A analogs allow to place this family of bacterially-derived molecules at the crossroads between innate and adaptive immunity. By virtue of this key position, the therapeutic applications being pursued aim at using these compounds either as direct anti-tumor agents or as vaccine adjuvants. The clinical experience acquired so far on these two avenues is asymmetric. Few clinical trials using Lipid A analogs as single anti-cancer agents involving less than 100 patients with advanced cancer have been reported. In contrast, lipid A has been tested in over 300,000 individuals in various vaccines trials, including therapeutic cancer vaccines. Clearly most of the work needed to develop lipid A as effective anti-cancer agents and/or as vaccine adjuvant lies ahead in the near future. This book is a timely contribution and provides a much needed up-to-date overview of the chemical, biological and physiological aspects of lipid A. It should be a beacon to all those involved in this field of research.
Product Identifiers
Publisher
Springer New York
ISBN-10
1441916024
ISBN-13
9781441916020
eBay Product ID (ePID)
78710177
Product Key Features
Publication Name
Lipid a in Cancer Therapy
Format
Hardcover
Language
English
Series
Advances in Experimental Medicine and Biology Ser.
Publication Year
2009
Type
Textbook
Number of Pages
152 Pages
Dimensions
Item Length
9.3in
Item Width
6.1in
Item Weight
12.7 Oz
Additional Product Features
Series Volume Number
667
Number of Volumes
1 Vol.
Lc Classification Number
R850.A1-854
Table of Content
Introduction: Historical Background.- Structure andSynthesis of Lipid A.- Conformation and Supramolecular Structure of Lipid A.- Interactions between Lipid A and Serum Proteins.- The Lipid A Receptor.- Lipid A Receptor TLR4-Mediated Signaling Pathways.- Lipid A-Induced Responses In Vivo.- Lipid A-Mediated Tolerance and Cancer Therapy.- Lipid A in Cancer Therapies Preclinical Results.- Monophosphoryl Lipid A (MPL) as an Adjuvant for Anti-Cancer Vaccines: Clinical Results.- Antitumoral Effects of Lipids A, Clinical Studies.- Conclusion.
Copyright Date
2010
Topic
Life Sciences / Cell Biology, Oncology, Research
Lccn
2009-035583
Dewey Decimal
616.99/4061
Intended Audience
Scholarly & Professional
Dewey Edition
22
Illustrated
Yes
Genre
Science, Medical
賣家提供的物品說明
運費與處理費
物品所在地：
Fairfield, Ohio, 美國
運送地點
不丹, 中國, 中國台灣, 中國澳門, 中國香港, 中非共和國, 丹麥, 乍德, 也門, 亞塞拜疆共和國, 亞美尼亞, 以色列, 伊拉克, 伯利茲, 佛得角群島, 保加利亞, 克羅地亞共和國, 全球, 冰島, 列支敦士登, 利比利亞, 剛果共和國, 剛果民主共和國, 加拿大, 加納, 加蓬共和國, 匈牙利, 南非, 南韓, 博茨瓦納, 卡塔爾, 印尼, 印度, 危地馬拉, 厄瓜多爾, 厄立特里亞, 吉布提, 吉爾吉斯, 哈薩克, 哥倫比亞, 哥斯達黎加, 喀麥隆, 圖瓦盧, 土庫斯安德凱科斯群島, 土庫曼, 土耳其, 圭亞那, 坦桑尼亞, 埃及, 埃塞俄比亞, 基里巴斯, 塔吉克, 塞內加爾, 塞拉利昂, 塞浦路斯, 塞爾維亞, 塞舌爾, 墨西哥, 多哥, 多明尼加, 多明尼加共和國, 奧地利, 孟加拉, 安哥拉, 安圭拉島, 安提瓜和巴布達, 安道爾, 寮國, 尼加拉瓜, 尼日利亞, 尼日爾, 尼泊爾, 巴哈馬, 巴基斯坦, 巴拉圭, 巴林, 巴西, 布基納法索, 布隆迪, 希臘, 幾內亞, 幾內亞比索, 庫克群島, 德國, 意大利, 愛沙尼亞, 愛爾蘭, 所羅門群島, 拉脫維亞, 挪威, 捷克共和國, 摩洛哥, 摩爾多瓦, 摩納哥, 斐濟, 斯威士蘭, 斯洛伐克, 斯洛文尼亞, 斯瓦爾巴群島和揚馬延島, 斯里蘭卡, 新加坡, 日本, 智利, 柬埔寨, 格恩西島, 格陵蘭, 格雷納達, 格魯吉亞, 梵蒂岡, 比利時, 毛里求斯, 汶萊, 沙特阿拉伯, 法國, 波斯尼亞和黑塞哥維那, 波蘭, 泰國, 津巴布韋, 洪都拉斯, 海地, 湯加, 澤西島, 澳洲, 烏干達, 烏拉圭, 烏茲別克, 牙買加, 特里尼達和多巴哥, 玻利維亞, 瑙魯, 瑞典, 瑞士, 瓦利斯和富圖納群島, 瓦努阿圖, 甘比亞, 百慕達群島, 盧旺達, 盧森堡, 直布羅陀, 福克蘭群島（馬爾維納斯）, 科威特, 科特迪瓦（象牙海岸）, 秘魯, 突尼斯, 立陶宛, 約旦, 納米比亞, 紐埃, 紐西蘭, 索馬里, 羅馬尼亞, 聖基茨-尼維斯, 聖文森和格瑞那丁, 聖皮耶與密克隆群島, 聖盧西亞, 聖赫倫那島, 聖馬力諾, 肯亞, 芬蘭, 英國, 英屬維爾京群島, 茅利塔尼亞, 荷屬安地列斯群島, 荷蘭, 莫桑比克, 菲律賓, 萊索托, 葛摩, 葡萄牙, 蒙古, 蒙特色拉特島, 薩爾瓦多, 蘇里南, 西撒哈拉, 西班牙, 貝寧, 贊比亞, 赤道幾內亞, 越南, 開曼群島, 阿富汗, 阿拉伯聯合酋長國, 阿曼, 阿根廷, 阿爾及利亞, 阿爾巴尼亞, 阿魯巴, 馬來西亞, 馬其頓, 馬拉維, 馬爾代夫, 馬約特島, 馬耳他, 馬達加斯加, 馬里, 黎巴嫩, 黑山
排除：
APO/FPO, 俄羅斯聯邦, 利比亞, 委內瑞拉, 巴布亞新畿內亞, 巴拿馬, 巴貝多, 新喀里多尼亞, 法屬圭亞那, 法屬玻里尼西亞, 烏克蘭, 瓜德羅普島, 留尼汪島, 白俄羅斯, 美國領地, 西薩摩亞, 阿拉斯加／夏威夷, 馬提尼克島
| 運費與處理費 | 運送地點 | 運送方式 | 運送*查看送達備註 |
|---|---|---|---|
| 免運費 | 美國 | Economy Shipping | 估計於 5月31日, 五至 6月11日, 二之間送達 運送地點 43230 |
| 處理時間 |
|---|
| 通常會在收到所有款項後的 3 個工作日內發貨。 |
| 稅項 |
|---|
| 結賬時相關稅項可能適用。 進一步了解進一步了解為 eBay 購物繳稅。 |
物品編號 364800573825 的銷售稅
物品編號 364800573825 的銷售稅
賣家會對寄往以下各州的物品收取銷售稅：
| 州／省 | 銷售稅稅率 |
|---|
退貨政策
| 收到物品後聯絡賣家的期限： | 退款方式 |
|---|---|
| 30 日 | 退款 |
買家負責支付退貨運費。
賣家信用評價 （1,023,560）
o***r (6167)- 買家留下的信用評價。
過去 1 個月
購買已獲認證
Prompt, courteous service. Highly recommend.
m***l (249)- 買家留下的信用評價。
過去 1 個月
購買已獲認證
The presentation method is good, but the adventures themselves are underwhelming. Many are more SF or Modern than fantasy, and many are best suited for children. Neither fact is clear from the book's marketing.
b***b (217)- 買家留下的信用評價。
過去 1 個月
購買已獲認證
Amazing transaction!!! Super fast delivery!! Thanks again! A++++++++++++++